Altrafin AG’s Teladoc Health TDOC Stock Holding History

Altrafin AG’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,000	Closed	-$532K	–	75
2023 Q2	$532K	Hold	21,000	–	–	0.24%	55
2023 Q1	$544K	Sell	21,000 -11,972	-36%	-$320K	0.27%	58
2022 Q4	$780K	Sell	32,972 -270	-0.8%	-$7.28K	0.46%	49
2022 Q3	$843K	Sell	33,242 -1,117	-3%	-$39.2K	0.5%	43
2022 Q2	$1.14M	Sell	34,359 -68	-0.2%	-$2.89K	0.62%	42
2022 Q1	$2.48M	Buy	34,427 +1,199	+4%	+$86.4K	0.98%	32
2021 Q4	$3.05M	Buy	+33,228	New	+$3.97M	1.1%	31

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Altrafin AG's TDOC Position: Q3 2023 in Review

Altrafin AG sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 21,000 shares — an estimated $532K sold.

Altrafin AG first reported a position in TDOC in Q4 2021 and held it in 7 quarters. The position peaked at $3.05M in Q4 2021. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

Altrafin AG reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
Altrafin AG sold 21,000 Teladoc Health shares in Q3 2023, an estimated $532K.
Altrafin AG first reported a position in Teladoc Health in Q4 2021 and held it in 7 quarters.
Altrafin AG's Teladoc Health position peaked at $3.05M in Q4 2021.
436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Altrafin AG's 13F filing for Q3 2023, filed 17 Feb 2026.